A novel hypoxia-selective epigenetic agent RRx-001 triggers apoptosis and overcomes drug resistance in multiple myeloma cells
Open Access
- 27 April 2016
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 30 (11) , 2187-2197
Abstract
The hypoxic bone marrow (BM) microenvironment confers growth/survival and drug resistance in multiple myeloma (MM) cells. Novel therapies targeting the MM cell in its hypoxic BM milieu may overcome drug resistance. Recent studies led to the development of a novel molecule RRx-001 with hypoxia-selective epigenetic and nitric oxide-donating properties. Here, we demonstrate that RRx-001 decreases the viability of MM cell lines and primary patient cells, as well as overcomes drug resistance. RRx-001 inhibits MM cell growth in the presence of BM stromal cells. RRx-001-induced apoptosis is associated with: (i) activation of caspases; (ii) release of ROS and nitrogen species; (iii) induction of DNA damage via ATM/γ-H2AX; and (iv) decrease in DNA methyltransferase (DNMT) and global methylation. RNA interference study shows a predominant role of DNMT1 in MM cell survival versus DNMT3a or DNMT3b. The deubiquitylating enzyme USP7 stimulates DNMT1 activity, and conversely, USP7-siRNA reduced DNMT1 activity and decreased MM cell viability. RRx-001 plus USP7 inhibitor P5091 triggered synergistic anti-MM activity. MM xenograft studies show that RRx-001 is well tolerated, inhibits tumor growth and enhances survival. Combining RRx-001 with pomalidomide, bortezomib or SAHA induces synergistic anti-MM activity. Our results provide the rationale for translation of RRx-001, either alone or in combination, to clinical evaluation in MM.Keywords
This publication has 59 references indexed in Scilit:
- Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple MyelomaCancers, 2013
- DNA damage induces reactive oxygen species generation through the H2AX-Nox1/Rac1 pathwayCell Death & Disease, 2012
- The USP7/Dnmt1 complex stimulates the DNA methylation activity of Dnmt1 and regulates the stability of UHRF1Nucleic Acids Research, 2011
- Angiogenesis and Multiple MyelomaCancer Microenvironment, 2011
- DNMT1 Stability Is Regulated by Proteins Coordinating Deubiquitination and Acetylation-Driven UbiquitinationScience Signaling, 2010
- Functional Interaction of Plasmacytoid Dendritic Cells with Multiple Myeloma Cells: A Therapeutic TargetCancer Cell, 2009
- Differential repetitive DNA methylation in multiple myeloma molecular subgroupsCarcinogenesis, 2009
- Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myelomaBlood, 2008
- Automethylation of G9a and its implication in wider substrate specificity and HP1 bindingNucleic Acids Research, 2007
- DNA methylation and gene silencing in cancerNature Clinical Practice Oncology, 2005